In pancreatic cancer patients receiving FOLFIRINOX, tumor size reduction significantly increased resectability and pathologic response. Normalization of carbohydrate antigen 19-9 levels predicted resectability, lower recurrence risk, and improved survival. Postoperative antigen 19-9 rise, following prior normalization after neoadjuvant therapy, signaled heightened recurrence risk and poorer survival. Tailoring treatment response assessments can guide personalized strategies for […]
Category: General Surgery
Sarcopenia Signals Poor Outcomes in Recurrent Hepatocellular Carcinoma
Patients with early-stage recurrent hepatocellular carcinoma and sarcopenia face significantly lower overall and recurrence-free survival rates, regardless of treatment type. Sarcopenia emerges as an independent prognostic factor, suggesting a crucial role in long-term outcomes. Notably, impaired host immunity, evidenced by low levels of tumor-infiltrating lymphocytes, may contribute to the unfavorable prognosis. This study underscores the […]
Optimizing Laparoscopic Pancreaticoduodenectomy: ‘1+2’ Stitch Shows Superiority in Pancreaticojejunostomy
In a game-changing move, researchers explored the “1+2” technique for pancreaticojejunostomy in laparoscopic pancreaticoduodenectomy. Among 184 cases, this approach exhibited success in all 95 “1+2” cases, showcasing advantages over the traditional method. The new technique boasted shorter operation and pancreaticojejunostomy times, reduced complications, lower infection rates, and briefer hospital stays. Results suggest that this innovative […]
Appendicitis Complexity Impacts Cancer Type
Analyzing 4 studies with 4,962 appendicitis patients, the meta-analysis found a 1.98% neoplasm incidence. No overall difference emerged between complicated (3.29%) and uncomplicated (1.49%) cases. Neuroendocrine tumors (NET) were common (49.21%), with higher rates in uncomplicated cases, while adenocarcinomas were more prevalent in complicated appendicitis (50% vs. 13%). Despite similar overall neoplasm rates, the study […]
DNA Methylation Classifier Illuminates Sarcoma Diagnoses and Molecular Markers
Researchers evaluated a sarcoma DNA methylation classifier for soft tissue and bone tumors, including 619 cases. The classifier exhibited high sensitivity and specificity for fusion sarcomas (Ewing, synovial, cic-rearranged, bcor-rearranged), leiomyosarcoma, MPNST, and malignant vascular tumors. However, sensitivity was low for desmoid fibromatosis, neurofibroma, and schwannoma, with low specificity for certain diagnoses. MDM2 amplification and […]
Low Morbidity and Laparoscopic Dominance: Insights from Chinese Study on Right Hemicolectomy for Colon Cancer
In a Chinese multi-center study on right hemicolectomy for colon cancer, involving 1,854 patients from 52 tertiary hospitals, laparoscopic surgery with D3 lymph node dissection was predominant. Postoperative morbidity and mortality were low at 11.7% and 0.2%, respectively. Anastomotic leak occurred in 1.4% of cases. Risk factors for morbidity included higher ASA grade, increased intraoperative […]
Synthetic Mesh Holds Its Own: Comparable Efficacy and Safety for Incisional Hernia Prevention in the Preloop Trial
In the “Preloop Trial,” where 102 patients underwent loop ileostomy closure, researchers compared retrorectus synthetic mesh to biological mesh for preventing incisional hernia. At 10 months, both groups showed similar low rates of incisional hernia—2% each. No significant differences were found in complications, reoperation, operating time, or hospital stay. This suggests synthetic mesh is as […]
Laparoscopic Limited Anatomic Liver Resections: Precise Technique Yields Promising Oncologic Outcomes
Exploring laparoscopic liver surgeries, researchers scrutinized 112 patients undergoing laparoscopically limited anatomic resections (LARs) for hepatocellular carcinoma (HCC) and colorectal liver metastasis (CRLM). Impressively, lap-LAR demonstrated precise technique, yielding promising oncologic outcomes with low complications. Five-year recurrence-free survival rates for HCC and CRLM stood at 45.1% and 36.8%, showcasing lap-LAR’s potential as an effective therapeutic […]
Tumor Biology and Surgical Margins Dictate Survival in Non-Metastatic Adrenocortical Carcinoma: A Paradigm Shift
In the battle against adrenocortical carcinoma (ACC), researchers find surgical approach and extent matter less than tumor biology and margins in non-metastatic cases. A cohort study (2010–2019, 1,175 subjects) reveals laparoscopic surgery, often considered minimally invasive, correlates with worse survival in advanced disease (stage III). Positive margins negatively impact survival, while chemoradiation benefits those with […]
Surgery Shines: A Viable Treatment Avenue for Stage IE Primary Thyroid Lymphoma
Surgery emerges as a viable treatment for stage IE primary thyroid lymphoma (PTL), with a cohort study of 1,596 patients (SEER database) and an external cohort of 38 patients (Shanghai, China). The 7.8-year SEER analysis showed no significant survival difference between surgery, surgery + radiotherapy/chemotherapy, and radiotherapy/chemotherapy alone. In the external cohort, surgery-alone exhibited comparable […]